TrialThe Journal of clinical endocrinology and metabolism2026

Sustained Action of Imapextide, A Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers.

Elisa Fabbrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.